PNPLA3 and metabolic dysfunction-associated steatotic liver disease: However, the primary role in the NAFLD development among non-obese patients was suggested for the PNPLA3 gene, even further elaborated to the PASH (PNPLA3-associated steatohepatitis) concept [184].